Home » Pharmaceuticals

Image for IDEXX Labs Acquires RADIL Reference Laboratory

IDEXX Labs Acquires RADIL Reference Laboratory

IDEXX Laboratories, Inc. (NASDAQ:IDXX) announced today that it has acquired the research and diagnostic laboratory (RADIL) business of the College of Veterinary Medicine from the University of Missouri.  IDEXX paid the the University... More of this article »
Image for AstraZeneca Launches $200 Million Dollar Facility in China

AstraZeneca Launches $200 Million Dollar Facility in China

AstraZeneca announced today that they have upped their investment stake in China with the launch of a $200 million dollar manufacturing facility in the country. The new plant will be in China Medical City (or, CMC), Taizhou, Jiangsu... More of this article »
Image for Merck Gets $175 Million from J&J Joint Venture Sale

Merck Gets $175 Million from J&J Joint Venture Sale

Merck announced today that they are removing themselves from participation in a joint venture called “Johnson & Johnson Merck Consumer Pharmaceuticals.” Merck had a 50% interest in the venture with Johnson & Johnson... More of this article »
Image for AstraZeneca’s FASLODEX Receives First Approval in Japan

AstraZeneca’s FASLODEX Receives First Approval in Japan

AstraZeneca announced today that their FASLODEX 500mg product received its first regulatory approval in Japan. FASLODEX 500mg is a breast cancer drug which had already gained regulatory approval in Europe in March, 2010 and in the... More of this article »
Image for Bristol-Myers & Ambrx Announce Exclusive Research Rights Deal

Bristol-Myers & Ambrx Announce Exclusive Research Rights Deal

Bristol-Myers Squibb & Ambrx, Inc. released a joint statement today which detailed a partnership where Bristol-Myers will gain exclusive worldwide rights to some of Ambrx’s research. In the agreement, Bristol-Myers will research,... More of this article »
Image for GlaxoSmithKline & Amicus Begin Second Phase 3 Study of Amigal

GlaxoSmithKline & Amicus Begin Second Phase 3 Study of Amigal

GlaxoSmithKline (GSK) announced today that they and Amicus Therapeutics have began the second phase III study of Amigal by way of dosing in a global registration study (Study 012) in an effort to compare safety and efficacy of Amigal... More of this article »
Image for Bristol-Myers Squibb Finalizes Acquisition of Amira Pharmaceuticals

Bristol-Myers Squibb Finalizes Acquisition of Amira Pharmaceuticals

The Bristol-Myers Squibb Company formally finalizes the acquisition of Amira Pharmaceuticals today. Amira Pharmaceuticals, Inc. had been a privately held company leading up to BMS’s acquisition of the company. Amira is noted... More of this article »
Image for Abbott’s on Dow Jones Sustainability Indexes for Seventh Consecutive Year

Abbott’s on Dow Jones Sustainability Indexes for Seventh Consecutive Year

Abbott has announced they have been included on not only the Dow Jones Sustainability World Index (DJSI) but also the North American index for seven consecutive years. The DJSI is a market benchmark for the performance of companies... More of this article »
Image for GE Healthcare Acquires PAA Laboratories GmbH

GE Healthcare Acquires PAA Laboratories GmbH

GE Healthcare Acquires PAA Laboratories GmbH in a bid to reinforce and strengthen biopharmaceutical manufacture segment of the company. The company announced today that they have entered a definitive agreement to acquire PAA Laboratories... More of this article »